You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Faltering growth

Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency

  • Highly specialised technologies guidance
  • Reference number: HST7
  • Published:  07 February 2018
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Expected publication
  2. Final evaluation determination
  3. Evaluation consultation: 1
  4. Invitation to participate
  5. Draft scope documents

History

Documents created during the development process.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 235 KB)

    Published:
    07 February 2018

Final evaluation determination

  • Final evaluation determination

  • Final evaluation determination document (PDF 440 KB)

    Published:
    28 December 2017
  • Committee papers (PDF 1.87 MB)

    Published:
    28 December 2017
  • Public committee slides (PDF 280 KB)

    Published:
    28 December 2017

Evaluation consultation: 1

  • Evaluation consultation: 1

  • Evaluation consultation document (PDF 477 KB)

    Published:
    23 October 2017
  • Public committee slides (PDF 1.03 MB)

    Published:
    23 October 2017
  • Committee papers (PDF 29.94 MB)

    Published:
    23 October 2017

Invitation to participate

  • Final scope (PDF 257 KB)

    Published:
    08 May 2017
  • NICE's response to comments on the draft scope and provisional matrix (PDF 251 KB)

    Published:
    08 May 2017
  • Final matrix (PDF 90 KB)

    Published:
    22 May 2017
  • Equality impact assessment (Scoping) (MSWord 40 KB)

    Published:
    08 May 2017

Draft scope documents

  • Draft scope (pre-referral) (PDF 114 KB)

    Published:
    13 April 2017
  • Provisional matrix (pre-referral) (PDF 99 KB)

    Published:
    13 April 2017
Back to top